Global coronavirus cases hit 20 million: Reuters tally

By Gayle Issa

(Reuters) – Global coronavirus cases pushed past 20 million on Monday, according to a Reuters tally, with the United States, Brazil and India accounting for more than half of all known infections.

The respiratory disease has infected at least four times the average number of people struck down with severe influenza illnesses annually, according to the World Health Organization.

The death toll from COVID-19, meanwhile, at more than 728,000 has outpaced the upper range of annual deaths from the flu.

The Reuters tally, which is based on government reports, shows the disease is accelerating. It took almost six months to reach 10 million cases after the first infection was reported in Wuhan, China, in early January. It took just 43 days to double that tally to 20 million.

Experts believe the official data likely under counts both infections and deaths, particularly in countries with limited testing capacity.

The United States is responsible for around 5 million cases, Brazil 3 million and India 2 million. Russia and South Africa round out the top ten.

The pandemic is accelerating fastest in Latin America which accounts for almost 28% of the world’s cases and more than 30% of deaths, according to the Reuters tally.

With the first wave of the virus yet to peak in some countries and a resurgence of cases in others, governments are still divided in their responses. Some countries are reintroducing strict public health measures, while others continue to relax restrictions.

Health experts expect dilemmas about how to proceed with school, work and social life to last – and restrictions to fluctuate – until a vaccine is available.

The vaccine race has more than 150 candidates being developed and tested around the world with 25 in human clinical trials, according to the World Health Organization.

In the United States, children began returning to their classrooms last week, even as controversy over school safety swirled.

Britain has added both Spain and Belgium to a list of countries from which returning travelers must quarantine at home for 14 days because of fresh upticks in some European locations.

In Asia, China continues to squash surges using strict, local lockdowns, bringing its daily numbers down into the low double digits on the mainland.

Australia has introduced a strict lockdown and night curfew in the city of Melbourne, aiming to stifle an outbreak there. Neighboring New Zealand, where life has largely returned to normal, on the weekend recorded 100 days with no new cases of local transmission.

(Reporting by Gayle Issa; editing by Jane Wardell)

China sends fighter jets as U.S. health chief visits Taiwan

By Yimou Lee and Ben Blanchard

TAIPEI (Reuters) – Chinese air force jets briefly crossed the mid-line of the Taiwan Strait on Monday and were tracked by Taiwanese missiles, Taiwan’s government said, as U.S. health chief Alex Azar visited the island to offer President Donald Trump’s support.

Azar arrived in Taiwan on Sunday, the highest-level U.S. official to visit in four decades.

China, which claims the island as its own, condemned the visit which comes after a period of sharply deteriorating relations between China and the United States.

China, which had promised unspecified retaliation to the trip, flew J-11 and J-10 fighter aircraft briefly onto Taiwan’s side of the sensitive and narrow strait that separates it from its giant neighbor, at around 9 am (0100 GMT), shortly before Azar met Taiwan President Tsai Ing-wen, Taiwan’s air force said.

The aircraft were tracked by land-based Taiwanese anti-aircraft missiles and were “driven out” by patrolling Taiwanese aircraft, the air force said in a statement released by the defense ministry.

China’s defense ministry did not immediately comment.

A senior Taiwan official familiar with the government’s security planning told Reuters that China was obviously “targeting” Azar’s visit with a “very risky” move given the Chinese jets were in range of Taiwan’s missiles.

The incursion was only the third time since 2016 that Taiwan has said Chinese jets had crossed the strait’s median line.

The Trump administration has made strengthening its support for the democratic island a priority, amid deteriorating relations between Washington and Beijing, and has boosted arms sales.

“It’s a true honor to be here to convey a message of strong support and friendship from President Trump to Taiwan,” Azar told Tsai in the Presidential Office, standing in front of two Taiwanese flags.

Washington broke off official ties with Taipei in 1979 in favor of Beijing.

‘HUGE STEP’

Azar is visiting to strengthen economic and public-health cooperation with Taiwan and support its international role in fighting the novel coronavirus.

“Taiwan’s response to COVID-19 has been among the most successful in the world, and that is a tribute to the open, transparent, democratic nature of Taiwan’s society and culture,” he told Tsai.

Taiwan’s early and effective steps to fight the disease have kept its case numbers far lower than those of its neighbors, with 480 infections and seven deaths. Most cases have been imported.

The United States, which has had more coronavirus cases and deaths than any other country, has repeatedly clashed with China over the pandemic, accusing Beijing of lacking transparency.

Tsai told Azar his visit represented “a huge step forward in anti-pandemic collaborations between our countries”, mentioning areas of cooperation including vaccine and drug research and production.

Taiwan has been particularly grateful for U.S. support to permit its attendance at the World Health Organization’s decision-making body the World Health Assembly (WHA), and to allow it greater access to the organisation.

Taiwan is not a member of the WHO due to China’s objections. China considers Taiwan a Chinese province.

“I’d like to reiterate that political considerations should never take precedence over the rights to health. The decision to bar Taiwan from participating in the WHA is a violation of the universal rights to health,” Tsai said.

Azar later told reporters that at Trump’s direction, he and Secretary of State Mike Pompeo had sought to restore Taiwan’s status as an observer at the WHA.

“But the Chinese Communist Party and the World Health Organization have prevented that. This has been one of the major frustrations that the Trump administration has had with the World Health Organization and its inability to reform.”

(Reporting by Ben Blanchard and Yimou Lee; Editing by Lincoln Feast, Robert Birsel)

Trump signs coronavirus relief orders after talks with Congress break down

By Jeff Mason

BEDMINSTER, N.J. (Reuters) – President Donald Trump signed executive orders on Saturday partly restoring enhanced unemployment payments to the tens of millions of Americans who lost jobs in the coronavirus pandemic, as the United States marked a grim milestone of 5 million cases.

Negotiations broke down this week between the White House and top Democrats in Congress over how best to help Americans cope with the heavy human and economic toll of the crisis, which has killed more than 160,000 people across the country.

Trump said the orders would provide an extra $400 per week in unemployment payments, less than the $600 per week passed earlier in the crisis. Some of the measures were likely to face legal challenges, as the U.S. Constitution gives Congress authority over federal spending.

“This is the money they need, this is the money they want, this gives them an incentive to go back to work,” the Republican president said of the lower payments. He said 25% of it would be paid by states, whose budgets have been hard hit by the crisis.

Republicans have argued that higher payments were a disincentive for unemployed Americans to try to return to work, though economists, including Federal Reserve officials, disputed that assertion.

Trump’s move to take relief measures out of the hands of Congress drew immediate criticism from some Democrats.

“Donald Trump is trying to distract from his failure to extend the $600 federal boost for 30 million unemployed workers by issuing illegal executive orders,” said Senator Ron Wyden, the top Democrat on the Senate Finance Committee. “This scheme is a classic Donald Trump con: playacting at leadership while robbing people of the support they desperately need.”

The Democratic-majority House of Representatives passed a coronavirus support package in May which the Republican-led Senate ignored.

Democratic presidential candidate Joe Biden called the orders a “series of half-baked measures” and accused Trump of putting Social Security “at grave risk” by delaying the collection of payroll taxes that pay for the program.

Trump also said he was suspending collection of payroll taxes, which pay for Social Security and other federal programs, an idea that he has repeatedly raised but has been rejected by both parties in Congress. He said the suspension would apply to people making less than $100,000 per year.

His orders would also stop evictions from rental housing that has federal financial backing and extend zero percent interest on federally financed student loans.

Trump initially played down the disease’s threat and has drawn criticism for inconsistent messages on public health steps such as social distancing and masks.

He spoke to reporters on Saturday at his New Jersey golf club, in a room that featured a crowd of cheering supporters.

FAR APART

Nearly two weeks of talks between White House officials and congressional Democrats ended on Friday with the two sides still about $2 trillion apart.

House Speaker Nancy Pelosi had pushed to extend the enhanced unemployment payments, which expired at the end of July, at the previous rate of $600 as well as to provide more financial support for city and state governments battered by the crisis.

Pelosi and Senate Minority Leader Chuck Schumer on Friday offered to reduce the $3.4 trillion coronavirus aid package that the House passed in May by nearly a third if Republicans would agree to more than double their $1 trillion counteroffer.

White House negotiators Treasury Secretary Steven Mnuchin and Chief of Staff Mark Meadows rejected the offer.

The $1 trillion package that Senate Majority Leader Mitch McConnell unveiled late last month ran into immediate opposition from his own party, with as many as 20 of the Senate’s 53 Republicans expected to oppose it.

Trump did not rule out a return to negotiations with Congress.

“I’m not saying they’re not going to come back and negotiate,” he said on Saturday. “Hopefully, we can do something with them at a later date.”

Democrats have already warned that such executive orders are legally dubious and would likely be challenged in court, but a court fight could take months.

Trump has managed to sidestep Congress on spending before, declaring a national emergency on the U.S.-Mexico border to shift billions of dollars from the defense budget to pay for a wall he promised during his 2016 election campaign.

Congress passed legislation to stop him, but there were too few votes in the Republican-controlled Senate to override his veto – a scenario that would likely play out again with less than 90 days to go before the Nov. 3 presidential election.

(Reporting by Jeff Mason, additional reporting by Raphael Satter, Brad Brooks, and Rich McKay; Writing by Scott Malone; Editing by Diane Craft, Daniel Wallis, Jonathan Oatis and Sonya Hepinstall)

Uber rides take COVID-19 hit but food-delivery business doubles

By Tina Bellon and Akanksha Rana

(Reuters) – Home-bound customers of Uber Technologies Inc. more than doubled their orders from the company’s food-delivery service in the second quarter but demand for ride-hailing trips only marginally recovered from pandemic rock-bottom.

The company said that despite those larger challenges it is sticking to its goal of being profitable on an adjusted basis before the end of 2021 thanks to stringent cost-cutting measures and a strong balance sheet. Uber recorded an adjusted loss in earnings before interest, taxes, depreciation and amortization of $837 million in the second quarter.

Shares were down 2.9% at $33.72 in after-hours trading.

Ride-hailing trips, in the past responsible for nearly two-thirds of Uber’s revenue, increased 5 percentage points from their low in April, but gross bookings remained down 75% from last year.

Uber’s chief executive officer, Dara Khosrowshahi, told analysts on a conference call on Thursday that rides recovery depended on the ability of different countries to contain the virus, with the recovery so far led by Asia, excluding India.

In Hong Kong and New Zealand, ride bookings at times exceeded pre-COVID-19 levels, while trip requests in Germany, France and Spain have improved to just a 35% decline from a year ago.

“Our global geographic footprint remains a huge advantage,” Khosrowshahi said.

The company on Thursday posted a $1.8 billion net loss from April through June, including charges related to laying off 23% of its global workforce during a period when infections of the novel coronavirus continued to spread in the United States, Uber’s largest market.

The number of active platform users across the 69 countries in which Uber operates nearly halved year-over-year, from 99 million to 55 million.

Uber’s second-quarter revenue fell 29% to $2.24 billion from the year prior, beating analysts’ average estimate of $2.18 billion, according to IBES data from Refinitiv.

Revenue at Uber Eats doubled to $1.2 billion, boosted by greater demand for delivery as Americans largely continue to stay home. Uber last month expanded its delivery reach by announcing the acquisition of Postmates Inc for $2.65 billion to expand the business of supplying everyday goods.

Uber’s ride-hailing segment remained battered by the coronavirus crisis, with revenue from the United States and Canada, its largest combined market, declining to $1.25 billion. Nevertheless, ride-hailing was the only segment generating an adjusted EBITDA profit, of $50 million.

Uber said fewer U.S. ride-hail drivers were returning to the platform compared with other countries. Uber faces several legal challenges over the status of its drivers in the United States, with California and Massachusetts suing the company over the alleged mis-classification of drivers as independent contractors.

Uber Eats, whose gross bookings more than doubled, narrowed losses, recording a $232 million adjusted EBITDA loss in the second quarter. Uber’s CFO, Nelson Chai, said the company expects third-quarter losses to be roughly the same.

He also told analysts that Uber’s food-delivery business would be profitable in the vast majority of countries in which it operates within a couple years.

Uber in recent months has closed Eats operations in eight smaller markets, including in Eastern Europe and the Middle East. It also cut losses from its Eats business in India, where it sold its food-ordering business to a local competitor in exchange for a stake in the company.

Uber Eats was also gaining traction in the suburbs, including the outer boroughs of New York City, where the food delivery service is now the market leader, the company said.

Uber executives said cost-cutting was helping to improve margins, along with better route planning and more restaurants relying on its delivery couriers.

(Reporting by Tina Bellon in New York and Akanksha Rana in Bangalore; Editing by Peter Henderson and Matthew Lewis)

U.S. surpasses 160,000 coronavirus deaths as school openings near

By Aurora Ellis and Maria Caspani

NEW YORK (Reuters) – More than 160,000 people have died from the coronavirus pandemic in the United States, nearly a quarter of the global total, according to a Reuters tally on Friday, as the country debates whether schools are ready to reopen in coming weeks.

The country recorded 160,003 deaths and 4.91 million cases, the highest caseload in the world, caused in part by lingering problems in making rapid testing widely available and resistance in some quarters to masks and social distancing measures.

Coronavirus deaths are rising in 23 states and cases are rising in 20 states, according to a Reuters analysis of data the past two weeks compared with the prior two weeks.

On a per-capita basis, the United States ranks 10th highest in the world for both cases and deaths.

Friday’s grim milestone marks an increase of 10,000 deaths in nine days in the United States.

Many of those died in California, Florida and Texas, the top three U.S. states for total cases. While new infections appear to be declining in those states, new outbreaks are emerging coast to coast.

Dr. Deborah Birx, the lead coordinator for the White House coronavirus response, warned of worrying upticks in the rate of tests coming back positive in several cities, including Boston, Chicago, Detroit and Washington.

Nearly 300,000 U.S. residents could be dead from COVID-19 by Dec. 1, University of Washington health experts said on Thursday, although they said 70,000 lives could be saved if Americans were scrupulous about wearing masks.

Throughout the country, U.S. officials, teachers’ unions, parents and students were debating how to reopen schools safely.

President Donald Trump has urged states to resume in-person classes, saying the virus “will go away like things go away,” but health officials have told states with rising counts to be on guard.

New York Governor Andrew Cuomo said on Friday some 700 school districts in the state could reopen classrooms, but insisted schools do extensive consultation with teachers, students and parents beforehand.

“If you look at our infection rate we are probably in the best situation in the country right now,” Cuomo told reporters. “If anybody can open schools, we can open schools.”

In New York City, where 1.1 million children attend the country’s largest network of public schools, Mayor Bill de Blasio has said students’ attendance will be limited to between one and three days each week. Parents in New York City have until Friday to request all-remote learning for their children.

Chicago Public Schools, which make up the country’s third largest school district, reversed course this week, saying students would stick with remote learning when the school year begins.

Some states, including Florida and Iowa, are mandating schools provide at least some in-person learning, while the governors of South Carolina and Missouri have recommended all classrooms reopen.

Texas had initially demanded that schools reopen but has since allowed districts to apply for waivers as the state grapples with a rising caseload. The Houston Independent School District has said that the school year will begin virtually on Sept. 8, but will shift to in-person learning on Oct. 19.

(Reporting by Aurora Ellis and Maria Caspani in New York; Additional reporting by Jonathan Allen in New York; Editing by Lisa Shumaker and Howard Goller)

U.S. travel warning puts virus-battered Mexico on par with war-torn nations

MEXICO CITY (Reuters) – The U.S. State Department urged citizens on Thursday not to travel to Mexico, despite easing a global travel ban, and warned of the rapid spread of coronavirus in the neighboring nation, in addition to rampant crime and kidnapping.

The United States and Mexico have close commercial ties and share the world’s busiest land border, crossed by many of their citizens for work, travel or family visits.

Mexico’s health ministry reported 6,590 new infections and 819 more deaths, taking its virus tally to 462,690 confirmed cases and 50,517 fatalities.

On Twitter, the U.S. ambassador to Mexico, Christopher Landau, said his country had issued a “Level 4: Do not travel,” warning for all nations at the beginning of the pandemic in March.

But the stringent advisory, usually reserved for countries at war, was not lifted for Mexico, because of the spread of COVID-19, the respiratory disease caused by the virus.

“Its own government recognizes that contagion rates are still high,” Landau added.

The state department said, “Travelers to Mexico may experience border closures, airport closures, travel prohibitions, stay at home orders, business closures, and other emergency conditions within Mexico due to COVID-19.”

Reiterating earlier concerns about crime, its website said the Level 4 warning covered Mexico and many other countries.

Also citing the spread of COVID-19, the U.S. Centers for Disease Control  and Prevention  (CDC)  issued a separate “Level 3 Travel Health Notice.”

(Reporting by Stefanie Eschenbacher; Editing by Clarence Fernandez)

Explainer: Trump wants to bypass U.S. coronavirus aid talks with executive order. Can he?

By Patricia Zengerle

WASHINGTON (Reuters) – With congressional Democrats and White House negotiators so far unable to agree on a deal to salve the heavy economic toll of the coronavirus pandemic, President Donald Trump has threatened to bypass Congress with an executive order.

Some of his proposals exceed his legal authority and would face immediate legal challenges, though in at least one case House of Representatives Speaker Nancy Pelosi, the nation’s top Democrat, told him to just go ahead.

WHAT DOES TRUMP WANT TO DO?

Trump said on Twitter he is considering executive orders to continue expanded unemployment benefits, reinstate a moratorium on evictions, cut payroll taxes and continue a suspension of student loan repayments amid a health crisis that has killed nearly 160,000 Americans.

He and administration officials negotiating with Congress have not provided specifics.

CAN HE DO IT?

The Constitution puts control of federal spending in the hands of Congress, not the president, so Trump does not have the legal authority to issue executive orders determining how money should be spent on coronavirus.

Democrats said executive orders would prompt a court fight, but legal action could take months.

Trump has sidestepped Congress on spending before. In 2019, he declared a national emergency at the border with Mexico to shift billions of dollars from the Pentagon budget to help pay for a promised wall that was the cornerstone of his 2016 election campaign.

Congress passed legislation to stop him, but there were too few votes in the Republican-controlled Senate to override his veto.

“There has to be a political will to do that and there has to be a priority given by members of Congress to assert their institutional interests,” said Mark Rozell, dean of the Schar School of Policy and Government at George Mason University in Virginia. “And that just isn’t there right now.”

WOULD DEMOCRATS OR REPUBLICANS OBJECT?

The $600 per week enhanced unemployment benefit in the massive “Cares Act” passed in March has been a major sticking point in negotiations. Democrats want to continue the federal payment, which expired on July 24, to the tens of millions who have lost their jobs in the crisis and have rejected a short-term extension. Trump’s fellow Republicans have argued that is too high a payment, contending it is a disincentive to work.

The moratorium on evictions was less contentious, and could be covered by reprogramming money that Congress has already approved for housing that has not been spent. Pelosi on Thursday said an order extending the moratorium “would be a good thing.”

Congressional Republicans and Democrats alike reject cutting the payroll tax, which is collected from both employers and employees to fund Social Security and Medicare. A cut would disproportionately benefit Americans with high salaries, and threaten funding for the popular programs for retirees. It also only benefits people still getting paychecks, not those who have lost their jobs.

The parties are closer together on student loans. Democrats included a 12-month extension of the student loan payment suspension in a relief bill the House passed in May. Republican senators did not include student loan relief in the proposal they unveiled in July. However, there is a Republican plan in Congress to extend the suspension for three months.

(Reporting by Patricia Zengerle; Editing by Scott Malone and Nick Zieminski)

Pfizer to make Gilead’s COVID-19 treatment remdesivir

(Reuters) – Pfizer Inc said on Friday it signed a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc, which is under pressure to increase tight supplies of the antiviral drug.

Gilead is aiming to make enough of the drug by the end of the year to treat more than 2 million COVID-19 patients, and agreed to send nearly all of its remdesivir supply to the United States through September.

But hospital staffers and politicians have complained about difficulties in gaining access to the drug, which is one of only two to have demonstrated an ability to help hospitalized COVID-19 patients in formal clinical trials.

There are also fears of shortages outside the United States, and separately on Friday, Britain’s Hikma Pharmaceuticals PLC said it has started manufacturing remdesivir at its Portugal plant.

Gilead said its manufacturing network for the drug had grown to more than 40 companies in North America, Europe and Asia to add capacity.

Earlier this week, a bipartisan group of U.S. state attorneys general urged the federal government to allow other companies to make Gilead’s remdesivir, to increase its availability and lower the price of the antiviral drug.

Pfizer will provide contract manufacturing services through its McPherson, Kansas, plant, the drugmaker said. It was not immediately clear if Pfizer would supply only for the U.S. market.

The U.S. Food and Drug Administration sent a warning letter to Pfizer in 2017 saying that the process for manufacturing sterile injectable drugs at the Kansas plant was “out of control” and put patients at risk.

The FDA said several products were contaminated with multiple foreign particulates but a subsequent FDA inspection found that the issues had been resolved.

Pfizer, with Germany’s BioNTech, is also rushing to develop a vaccine against the coronavirus.

Pfizer has helped other drugmakers manufacture their products before. It makes EpiPen emergency allergy treatments through its Meridian Medical Technologies business and also operates a contract manufacturer called Center One.

(Reporting by Manas Mishra in Bengaluru; Editing by Anil D’Silva and Matthew Lewis)

UK’s Hikma making Gilead’s COVID-19 drug remdesivir to increase supply

By Pushkala Aripaka

(Reuters) – Britain’s Hikma Pharmaceuticals said on Friday it has started manufacturing Gilead’s antiviral drug remdesivir under contract in Portugal, as the U.S. company outsources to increase availability of the COVID-19 treatment.

Remdesivir is one of only two medicines to have shown to help hospitalized COVID-19 patients in clinical trials, making it a front-runner treatment for the illness caused by the new coronavirus.

Hikma’s Chief Executive Siggi Olafsson said the company will start supplying batches of the drug “soon,” and Gilead is expected to distribute it.

“The terms of the deal are confidential, we are simply a contract manufacturer for Gilead – they order products from us as they expect the sales to be,” Olafsson told Reuters in a telephone interview.

Remdesivir, which is administered intravenously, has been conditionally approved or supported in many regions to treat COVID-19, which has killed more than 800,000 people globally.

A pledge by Gilead to send nearly all of its supplies to the United States between July and September stirred concerns about availability elsewhere.

This week, a bipartisan group of U.S. state attorney generals urged Washington to allow other companies to make the treatment to increase availability and lower the price.

On Friday, Pfizer said it had signed a multi-year deal with Gilead to manufacture and supply remdesivir.

Gilead said on Thursday that its manufacturing network for the drug had grown to more than 40 companies in North America, Europe and Asia.

The company had said in June that it was aiming to supply enough of the drug by the end of the year to treat more than 2 million COVID-19 patients, more than double its prior target of 1 million.

Gilead has signed several pacts with generic medicine makers in Egypt, India and Pakistan to distribute remdesivir in 127 countries. The deals include those with Cipla Jubilant and privately held Hetero.

Hikma’s announcement of the deal with Gilead helped its shares jump more than 10% on Friday as it also reported a jump in first-half operating profit and lifted its sales outlook.

Analysts said the deal highlights Hikma’s “growing importance as a trusted source of essential medicines.”

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur/Josephine Mason/Susan Fenton)

Ohio governor tests positive for COVID-19, cancels plans to greet Trump in Cleveland

WASHINGTON (Reuters) – Ohio Governor Mike DeWine said on Thursday he had tested positive for COVID-19 as part of a safety protocol to greet U.S. President Donald Trump when he arrives in Cleveland to visit a Whirlpool washing machine factory.

A statement issued on DeWine’s Twitter feed said the governor, a Republican, had no symptoms at the present time and would return to the Ohio capital of Columbus to quarantine at home for the next 14 days. Ohio Lieutenant Governor Jon Husted also took the coronavirus test and tested negative, DeWine’s statement said.

White House Chief of Staff Mark Meadows said alternate arrangements were being made for greeting Trump and there would be no major changes to the president’s itinerary in Ohio.

“The President wishes Governor DeWine a speedy and full recovery and commends the job he’s doing for the great state of Ohio,” said White House spokesman Judd Deere.

At the Whirlpool plant in Clyde, Ohio, Trump will tout the tariffs his administration imposed on imported washing machines in 2018, which have helped increase employment at the facility while contributing to price increases for the appliances.

Trump also plans to sign a long-awaited executive order aimed at boosting U.S. production of drugs and medical equipment, including through a “Buy America” provision requiring the government to buy from domestic firms and other measures..

Later on Thursday, Trump is due to attend fundraising events at a Cleveland-area yacht club and at the Trump National Golf Club in Bedminster, New Jersey.

(Reporting by David Lawder; Editing by Chris Reese and Tom Brown)